From the Research
The treatment of dyshidrotic eczema should prioritize the use of potent topical corticosteroids, such as betamethasone valerate 0.1% or clobetasol propionate 0.05%, applied once daily for 2-4 weeks to reduce inflammation and itching, as evidenced by a recent study 1. This approach is supported by the findings of a Cochrane review 1, which suggests that potent topical corticosteroids are probably more effective than mild topical corticosteroids in treating eczema, particularly in moderate or severe cases. The use of topical corticosteroids should be balanced with the risk of local adverse events, such as abnormal skin thinning, which is more common with higher-potency topical corticosteroids 1. Additionally, moisturizing regularly with fragrance-free emollients and avoiding triggers, such as irritants like soaps and detergents, are essential components of the treatment plan. For severe cases, oral antihistamines or short courses of oral prednisone may be necessary, while persistent cases may require phototherapy or immunosuppressants like cyclosporine 2. It is also important to note that some treatments, such as oral antihistamines and topical antistaphylococcal treatments, have limited evidence to support their use in eczema treatment 2. Key considerations in the treatment of dyshidrotic eczema include:
- Using potent topical corticosteroids once daily to reduce inflammation and itching
- Moisturizing regularly with fragrance-free emollients to maintain skin barrier function
- Avoiding triggers, such as irritants like soaps and detergents
- Considering oral antihistamines or short courses of oral prednisone for severe cases
- Using phototherapy or immunosuppressants like cyclosporine for persistent cases
- Being aware of the potential risks and limitations of different treatments, as highlighted in recent studies 1, 2.